{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:24:25Z","timestamp":1794857065067,"version":"4.9.1"},"reference-count":207,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.xphs.2017.04.053","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T20:30:44Z","timestamp":1493497844000},"page":"2282-2294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Effect of Liver Disease on Hepatic Transporter Expression and Function"],"prefix":"10.1016","volume":"106","author":[{"given":"Nilay","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Slizgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.xphs.2017.04.053_bib2","series-title":"Hepatic Transporter Function in Liver Disease: Impact on Hepatobiliary Disposition and Pharmacokinetics","author":"Slizgi","year":"2016"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib3","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI117091","article-title":"Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter","volume":"93","author":"Hagenbuch","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib4","first-page":"331","article-title":"Electrogenicity of Na(+)-coupled bile acid transporters","volume":"70","author":"Weinman","year":"1997","journal-title":"YaleJ Biol Med"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007226","article-title":"Sinusoidal (basolateral) bile salt uptake systems of hepatocytes","volume":"16","author":"Hagenbuch","year":"1996","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.bcp.2006.12.027","article-title":"Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases","volume":"73","author":"Vallejo","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xphs.2017.04.053_bib8","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib9","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/ijms15022892","article-title":"NTCP and beyond: opening the door to unveil hepatitis B virus entry","volume":"15","author":"Watashi","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"10-11","key":"10.1016\/j.xphs.2017.04.053_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/00498250600861751","article-title":"Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition","volume":"36","author":"Bleasby","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2017.04.053_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1242\/jcs.107.4.1065","article-title":"Molecular cloning and characterization of a novel liver-specific transport protein","volume":"107","author":"Simonson","year":"1994","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.xphs.2017.04.053_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-14541-4_2","article-title":"In\u00a0vitro and in\u00a0vivo evidence of the importance of organic anion transporters (OATs) in drug therapy","volume":"201","author":"Burckhardt","year":"2011","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib13","doi-asserted-by":"crossref","first-page":"F216","DOI":"10.1152\/ajprenal.2000.279.2.F216","article-title":"Molecular pharmacology of renal organic anion transporters","volume":"279","author":"Van Aubel","year":"2000","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02738157","article-title":"The molecular biology of renal organic anion and organic cation transporters","volume":"31","author":"Sweet","year":"1999","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1124\/mol.107.043117","article-title":"Organic Anion Transporter 2 (SLC22A7) is a facilitative transporter of cGMP","volume":"73","author":"Cropp","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/mol.62.1.7","article-title":"Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice","volume":"62","author":"Kobayashi","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/bbrc.2001.4774","article-title":"Isolation of a family of organic anion transporters from human liver and kidney","volume":"283","author":"Sun","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"30","key":"10.1016\/j.xphs.2017.04.053_bib18","doi-asserted-by":"crossref","first-page":"18526","DOI":"10.1074\/jbc.272.30.18526","article-title":"Expression cloning and characterization of a novel multispecific organic anion transporter","volume":"272","author":"Sekine","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.301.3.797","article-title":"Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors","volume":"301","author":"Enomoto","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.21596","article-title":"Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate","volume":"45","author":"Shin","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/tpj.2015.55","article-title":"Variability in hepatic expression of organic anion transporter 7\/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors","volume":"16","author":"Emami Riedmaier","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.114.062034","article-title":"Meta-analysis of expression of hepatic organic anion-transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue","volume":"43","author":"Bad\u00e9e","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"7-8","key":"10.1016\/j.xphs.2017.04.053_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib25","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1073\/pnas.0304987101","article-title":"Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney","volume":"101","author":"Mikkaichi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.xphs.2017.04.053_bib26","doi-asserted-by":"crossref","first-page":"26340","DOI":"10.1074\/jbc.272.42.26340","article-title":"Organic anion transporting polypeptide mediates organic anion\/HCO3- exchange","volume":"272","author":"Satlin","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"26","key":"10.1016\/j.xphs.2017.04.053_bib27","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1074\/jbc.273.26.16184","article-title":"Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter","volume":"273","author":"Li","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/mol.58.2.335","article-title":"Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione","volume":"58","author":"Li","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2017.04.053_bib30","series-title":"Guidance for Industry Drug Interaction Studies\u2014Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations","year":"2012"},{"issue":"6506","key":"10.1016\/j.xphs.2017.04.053_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/372549a0","article-title":"Drug excretion mediated by a new prototype of polyspecific transporter","volume":"372","author":"Gr\u00fcndemann","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.xphs.2017.04.053_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10254-003-0017-x","article-title":"Organic cation transporters","volume":"150","author":"Koepsell","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib33","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/jpet.105.091223","article-title":"Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)","volume":"315","author":"Bourdet","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.114.220350","article-title":"Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers","volume":"352","author":"Han","year":"2015","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib35","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.29965","article-title":"Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells","volume":"138","author":"Cai","year":"2016","journal-title":"Int J Cancer"},{"issue":"47","key":"10.1016\/j.xphs.2017.04.053_bib36","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","article-title":"Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)","volume":"22","author":"Doyle","year":"2003","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.053_bib37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/PL00000912","article-title":"From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance","volume":"58","author":"Litman","year":"2001","journal-title":"Cell Mol Life Sci"},{"issue":"19","key":"10.1016\/j.xphs.2017.04.053_bib38","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"Xu","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1006\/bbrc.2001.4267","article-title":"Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells","volume":"280","author":"Kawabata","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"10.1016\/j.xphs.2017.04.053_bib40","first-page":"4559","article-title":"Overexpression of the BCRP\/MXR\/ABCP gene in a topotecan-selected ovarian tumor cell line","volume":"59","author":"Maliepaard","year":"1999","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.xphs.2017.04.053_bib41","first-page":"6175","article-title":"Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells","volume":"52","author":"Nakagawa","year":"1992","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib42","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejps.2005.12.007","article-title":"Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites","volume":"27","author":"Zamek-Gliszczynski","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/jpet.105.084830","article-title":"Bile salt export pump (BSEP\/ABCB11) can transport a nonbile acid substrate, pravastatin","volume":"314","author":"Hirano","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"16","key":"10.1016\/j.xphs.2017.04.053_bib45","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","article-title":"The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver","volume":"273","author":"Gerloff","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng1147","article-title":"Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT","volume":"34","author":"Carlton","year":"2003","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.36591","article-title":"The human bile salt export pump: characterization of substrate specificity and identification of inhibitors","volume":"123","author":"Byrne","year":"2002","journal-title":"Gastroenterology"},{"issue":"50","key":"10.1016\/j.xphs.2017.04.053_bib48","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","article-title":"A\u00a0human transporter protein that mediates the final excretion step for toxic organic cations","volume":"102","author":"Otsuka","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.xphs.2017.04.053_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","article-title":"Organic cation transporters (OCTs, MATEs), in\u00a0vitro and in\u00a0vivo evidence for the importance in drug therapy","volume":"201","author":"Nies","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.xphs.2017.04.053_bib50","first-page":"55","article-title":"The canalicular conjugate export pump encoded by the cmrp\/cmoat gene","volume":"14","author":"Keppler","year":"1996","journal-title":"Prog Liver Dis"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib51","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1681\/ASN.V1061159","article-title":"Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma","volume":"10","author":"Schaub","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2559.2002.01403.x","article-title":"Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays","volume":"41","author":"Sandusky","year":"2002","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.053_bib53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/dmd.104.003335","article-title":"Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation","volume":"33","author":"Meyer zu Schwabedissen","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib54","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1476-5381.2011.01672.x","article-title":"Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells","volume":"165","author":"Fahrmayr","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"25","key":"10.1016\/j.xphs.2017.04.053_bib55","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1074\/jbc.271.25.15091","article-title":"cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats","volume":"271","author":"B\u00fcchler","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/03602530903491741","article-title":"ABCC2\/Abcc2: a multispecific transporter with dominant excretory functions","volume":"42","author":"Jemnitz","year":"2010","journal-title":"Drug Metab Rev"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/dmd.113.055772","article-title":"The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia","volume":"42","author":"Keppler","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib58","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1124\/jpet.106.104018","article-title":"Disposition and sterol-lowering effect of ezetimibe in multidrug resistance-associated protein 2-deficient rats","volume":"318","author":"Oswald","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib59","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1074\/jbc.270.2.843","article-title":"Membrane topology of a cysteine-less mutant of human P-glycoprotein","volume":"270","author":"Loo","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib60","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues","volume":"38","author":"Cordon-Cardo","year":"1990","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib61","first-page":"389","article-title":"Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in\u00a0vitro resistance to taxol and doxorubicin","volume":"4","author":"Mechetner","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.xphs.2017.04.053_bib62","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/jnci\/93.16.1234","article-title":"Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance","volume":"93","author":"Vredenburg","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.xphs.2017.04.053_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"issue":"20","key":"10.1016\/j.xphs.2017.04.053_bib64","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2174\/092986708785132870","article-title":"Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development","volume":"15","author":"Zhou","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.xphs.2017.04.053_bib65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-14541-4_8","article-title":"Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy","volume":"201","author":"Keppler","year":"2011","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bse0500179","article-title":"Mammalian multidrug-resistance proteins (MRPs)","volume":"50","author":"Slot","year":"2011","journal-title":"Essays Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib67","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.febslet.2005.12.036","article-title":"Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)","volume":"580","author":"Deeley","year":"2006","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/mol.52.3.344","article-title":"Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells","volume":"52","author":"Stride","year":"1997","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/labinvest.3780411","article-title":"Tissue distribution and induction of human multidrug resistant protein 3","volume":"82","author":"Scheffer","year":"2002","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib70","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.24801","article-title":"Elevated hepatic MRP3\/ABCC3 expression in human obstructive cholestasis is mediated through TNF\u03b1 and JNK\/SAPK signaling pathway","volume":"55","author":"Chai","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/jhep.2001.26213","article-title":"Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver","volume":"34","author":"Donner","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib73","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1074\/jbc.275.4.2905","article-title":"ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)","volume":"275","author":"Hirohashi","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib74","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/dmd.114.062703","article-title":"Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis","volume":"43","author":"Canet","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"19","key":"10.1016\/j.xphs.2017.04.053_bib75","first-page":"7225","article-title":"Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport","volume":"61","author":"Zeng","year":"2001","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib76","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.18632\/oncotarget.6889","article-title":"MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma","volume":"7","author":"Tomonari","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib77","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1124\/dmd.30.9.962","article-title":"Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab Dispos"},{"issue":"Pt 2","key":"10.1016\/j.xphs.2017.04.053_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021886","article-title":"Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)","volume":"371","author":"Zelcer","year":"2003","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.tpj.6500451","article-title":"Variability in human hepatic MRP4 expression: influence of cholestasis and genotype","volume":"8","author":"Gradhand","year":"2008","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib80","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.21158","article-title":"Mrp4-\/- mice have an impaired cytoprotective response in obstructive cholestasis","volume":"43","author":"Mennone","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0005-2736(02)00657-0","article-title":"Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat","volume":"1609","author":"Geier","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib82","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib83","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1203\/PDR.0b013e318170a6b5","article-title":"Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia","volume":"63","author":"Chen","year":"2008","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib84","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1124\/dmd.107.020073","volume":"36","author":"Nakai","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2133\/dmpk.DMPK-11-RG-077","article-title":"Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development","volume":"27","author":"Hanada","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.053_bib86","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.109.031732","article-title":"Effect of hepatitis C virus infection on the mRNA expression of drug transporters and cytochrome p450 enzymes in chimeric mice with humanized liver","volume":"38","author":"Kikuchi","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib87","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","article-title":"Hepatobiliary transporter expression in human hepatocellular carcinoma","volume":"25","author":"Zollner","year":"2005","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib88","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/hep.510230518","article-title":"Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells","volume":"23","author":"Kullak-Ublick","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1665-2681(19)31170-6","article-title":"The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease","volume":"14","author":"Aguilar-Olivos","year":"2015","journal-title":"Ann Hepatol"},{"issue":"1-3","key":"10.1016\/j.xphs.2017.04.053_bib91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2009.04.002","article-title":"Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats","volume":"613","author":"Fisher","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.053_bib92","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","article-title":"The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease","volume":"51","author":"Okushin","year":"2016","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib93","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib94","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0168-8278(03)00410-0","article-title":"Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis","volume":"39","author":"Kojima","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib95","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/dmd.112.049676","article-title":"Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver","volume":"41","author":"More","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib96","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2003.10.008","article-title":"The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma","volume":"40","author":"Vavricka","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib97","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.LAB.0000065015.02412.48","article-title":"Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma","volume":"83","author":"Cui","year":"2003","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib98","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1535-7163.MCT-06-0500","article-title":"Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells","volume":"6","author":"Monks","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib99","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/jpet.106.106591","article-title":"Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver","volume":"319","author":"Libra","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/path.1852","article-title":"Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver","volume":"207","author":"Vander Borght","year":"2005","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jhep.2014.02.021","article-title":"Synergistic interaction between genetics and disease on pravastatin disposition","volume":"61","author":"Clarke","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib103","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/dmd.113.055996","article-title":"Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models","volume":"42","author":"Canet","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib104","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1872-034X.2011.00912.x","article-title":"Hepatobiliary membrane transporters in primary biliary cirrhosis","volume":"42","author":"Takeyama","year":"2012","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1148\/radiol.10091557","article-title":"Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging\u2013correlation with expression of sinusoidal and canalicular transporters and bile accumulation","volume":"255","author":"Tsuboyama","year":"2010","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib106","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.113.211284","article-title":"Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression","volume":"348","author":"Clarke","year":"2014","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib107","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/dmd.115.067827","article-title":"Endotoxin-mediated downregulation of hepatic drug transporters in HIV-1 transgenic rats","volume":"44","author":"Ghoneim","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib108","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0016-5085(97)70103-3","article-title":"The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis","volume":"113","author":"Trauner","year":"1997","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.053_bib109","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/gm298","article-title":"DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma","volume":"3","author":"Schaeffeler","year":"2011","journal-title":"Genome Med"},{"key":"10.1016\/j.xphs.2017.04.053_bib110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2407-12-109","article-title":"Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance","volume":"12","author":"Heise","year":"2012","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib111","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/path.1379","article-title":"High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease","volume":"200","author":"Ros","year":"2003","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib112","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF03402158","article-title":"Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases","volume":"8","author":"Bonin","year":"2002","journal-title":"Mol Med"},{"issue":"48","key":"10.1016\/j.xphs.2017.04.053_bib113","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.3748\/wjg.v16.i48.6104","article-title":"Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma","volume":"16","author":"Zhao","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.053_bib114","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2133\/dmpk.25.190","article-title":"Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters","volume":"25","author":"Ogasawara","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib116","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep.24682","article-title":"Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs","volume":"55","author":"Borel","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib117","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1734-1140(12)70888-5","article-title":"Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1","volume":"64","author":"Kurzawski","year":"2012","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib118","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-230X-12-160","article-title":"Gene and functional up-regulation of the BCRP\/ABCG2 transporter in hepatocellular carcinoma","volume":"12","author":"Sukowati","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib119","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/030089161009600115","article-title":"Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in\u00a0vivo and clinical studies","volume":"96","author":"Sun","year":"2010","journal-title":"Tumori"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfu156","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","volume":"142","author":"Hardwick","year":"2014","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib121","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.27171","article-title":"Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy","volume":"60","author":"Song","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib122","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.26187","article-title":"Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib123","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.053_bib124","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1124\/dmd.114.059832","article-title":"Differential expression of drug uptake and efflux transporters in Japanese patients with hepatocellular carcinoma","volume":"42","author":"Namisaki","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib125","first-page":"73","article-title":"Expression of multidrug resistance (p-glycoprotein) mdr1 and mdr2 genes in human hepatocellular carcinomas and liver metastases of colonic tumors","volume":"2","author":"Teeter","year":"1993","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1309\/AC1M-4TY4-U0TN-EN7T","article-title":"Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response","volume":"113","author":"Ng","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib127","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000227694","article-title":"Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma","volume":"54","author":"Takanishi","year":"2009","journal-title":"Oncology"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib128","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/00498254.2013.783250","article-title":"Effects of 17\u03b1-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin","volume":"43","author":"Choi","year":"2013","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11095-008-9770-5","article-title":"Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis","volume":"26","author":"Jin","year":"2009","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.49.2.643-649.2005","article-title":"Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects","volume":"49","author":"Regazzi","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MNM.0b013e328334bff7","article-title":"Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation","volume":"31","author":"Kula","year":"2010","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib132","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/dmd.108.024315","article-title":"Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1)","volume":"37","author":"van de Steeg","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib133","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI1269","article-title":"The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors","volume":"101","author":"Kim","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib134","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cpt.66","article-title":"Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis","volume":"97","author":"Ferslew","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.053_bib135","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1007\/s00330-011-2228-x","article-title":"Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression","volume":"21","author":"Tsuda","year":"2011","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib136","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.116.234310","article-title":"Biliary elimination of pemetrexed is dependent on Mrp2 in rats: potential mechanism of variable response in nonalcoholic steatohepatitis","volume":"358","author":"Dzierlenga","year":"2016","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib137","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1111\/hepr.12470","article-title":"Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis","volume":"45","author":"Takeyama","year":"2015","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib138","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1969.02100030114014","article-title":"Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred","volume":"117","author":"Clayton","year":"1969","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.xphs.2017.04.053_bib139","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36 Suppl 1","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib140","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20682","article-title":"Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis","volume":"41","author":"Keitel","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib141","doi-asserted-by":"crossref","first-page":"e28343","DOI":"10.1371\/journal.pone.0028343","article-title":"Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort","volume":"7","author":"Rook","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib142","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/me.2015-1014","article-title":"Estrogen and estrogen receptor-\u03b1-mediated transrepression of bile salt export pump","volume":"29","author":"Chen","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib143","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1053\/jhep.2002.33327","article-title":"Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis","volume":"35","author":"Mottino","year":"2002","journal-title":"Hepatology"},{"issue":"6 Pt 1","key":"10.1016\/j.xphs.2017.04.053_bib144","first-page":"G1043","article-title":"Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters","volume":"271","author":"Simon","year":"1996","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib145","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00404-011-2183-4","article-title":"Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy","volume":"285","author":"Wang","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib146","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hep.510310319","article-title":"Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver","volume":"31","author":"Paulusma","year":"2000","journal-title":"Hepatology"},{"issue":"7 Pt 2","key":"10.1016\/j.xphs.2017.04.053_bib147","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/j.1440-1746.2007.05109.x","article-title":"Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases","volume":"23","author":"Kojima","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib148","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejps.2012.03.006","article-title":"The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells","volume":"46","author":"He","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib149","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jhep.2015.09.020","article-title":"MRP2 in cholestasis: putting down the anchor","volume":"63","author":"Elferink","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxlet.2013.09.019","article-title":"Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes","volume":"224","author":"Guo","year":"2014","journal-title":"Toxicol Lett"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib151","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1211\/jpp.61.09.0010","article-title":"Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis","volume":"61","author":"Hasegawa","year":"2009","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib152","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/jps.2600650921","article-title":"Influence of cholestasis on drug elimination: pharmacokinetics","volume":"65","author":"Harrison","year":"1976","journal-title":"J\u00a0Pharm Sci"},{"issue":"1 Suppl","key":"10.1016\/j.xphs.2017.04.053_bib153","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib154","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1440-1746.2008.05384.x","article-title":"Hepatitis B virus\/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment","volume":"23","author":"Chu","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib155","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1440-1746.2009.05800.x","article-title":"Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease","volume":"24","author":"Congiu","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib156","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/jhep.2002.32470","article-title":"Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity","volume":"35","author":"Tsutsumi","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib157","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/v1020126","article-title":"Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress","volume":"1","author":"Cl\u00e9ment","year":"2009","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.053_bib158","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1124\/dmd.116.071050","article-title":"Transporter expression in liver tissue from subjects with alcoholic or hepatitis C cirrhosis quantified by targeted quantitative proteomics","volume":"44","author":"Wang","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.053_bib159","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1478-3231.2007.01506.x","article-title":"Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis","volume":"27","author":"Zollner","year":"2007","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2010.01.013","article-title":"Nrf2 the rescue: effects of the antioxidative\/electrophilic response on the liver","volume":"244","author":"Klaassen","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib161","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/mol.61.4.853","article-title":"Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells","volume":"61","author":"Briz","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"26","key":"10.1016\/j.xphs.2017.04.053_bib162","doi-asserted-by":"crossref","first-page":"18598","DOI":"10.1016\/S0021-9258(19)37003-6","article-title":"Liver-specific drug targeting by coupling to bile acids","volume":"267","author":"Kramer","year":"1992","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib163","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1208\/s12248-015-9740-x","article-title":"Role of organic anion-transporting polypeptides (OATPs) in cancer therapy","volume":"17","author":"Thakkar","year":"2015","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib164","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bcp.2013.07.020","article-title":"Role of hypoxia inducible factor-1a in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer","volume":"86","author":"Han","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.053_bib165","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/gast.2001.24804","article-title":"LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers","volume":"120","author":"Abe","year":"2001","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib166","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1349-7006.2007.00570.x","article-title":"Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma","volume":"98","author":"Muto","year":"2007","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib167","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/mp3005353","article-title":"A\u00a0cancer-specific variant of the slco1b3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells","volume":"10","author":"Thakkar","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2017.04.053_bib168","first-page":"27","article-title":"Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets","volume":"4","author":"Kounnis","year":"2011","journal-title":"Onco Targets Ther"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.053_bib169","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1158\/1078-0432.CCR-07-4118","article-title":"Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer","volume":"14","author":"Hamada","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.xphs.2017.04.053_bib170","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1158\/0008-5472.CAN-08-1984","article-title":"Overexpression of OATP1B3 confers apoptotic resistance in colon cancer","volume":"68","author":"Lee","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2017.04.053_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CEG.S3743","article-title":"Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome","volume":"1","author":"Lockhart","year":"2008","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.xphs.2017.04.053_bib172","first-page":"863539","article-title":"Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy","volume":"2013","author":"Buxhofer-Ausch","year":"2013","journal-title":"J\u00a0Drug Deliv"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib173","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4161\/cbt.11.9.15176","article-title":"The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer","volume":"11","author":"Wlcek","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.053_bib174","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1872-034X.2008.00381.x","article-title":"Up-regulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: a study in patients and in\u00a0vitro","volume":"38","author":"Vander Borght","year":"2008","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib176","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2007.06.001","article-title":"Endogenous bile acids as carcinogens","volume":"47","author":"Jansen","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"27","key":"10.1016\/j.xphs.2017.04.053_bib177","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.3748\/wjg.15.3329","article-title":"Bile acids as endogenous etiologic agents in gastrointestinal cancer","volume":"15","author":"Bernstein","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.053_bib178","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbalip.2010.04.006","article-title":"Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease","volume":"1801","author":"Gadaleta","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.053_bib179","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1440-1746.1997.tb00487.x","article-title":"Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation","volume":"12","author":"Chou","year":"1997","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.xphs.2017.04.053_bib180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-011613-140021","article-title":"Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics","volume":"54","author":"Pfeifer","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib181","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijc.1498","article-title":"Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma","volume":"94","author":"Nies","year":"2001","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib182","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences","volume":"214","author":"Appay","year":"2008","journal-title":"J\u00a0Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib183","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines\u00a0tumor necrosis factor- or interleukin-6","volume":"37","author":"Vee","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"41","key":"10.1016\/j.xphs.2017.04.053_bib184","doi-asserted-by":"crossref","first-page":"31185","DOI":"10.1074\/jbc.M110.107805","article-title":"Regulation of MRP2\/ABCC2 and BSEP\/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-, IL-6, and IL-1","volume":"285","author":"Diao","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.2003.02064.x","article-title":"Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients","volume":"131","author":"Brazille","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.053_bib186","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jcph.132","article-title":"Expression of membrane drug efflux transporters in the sigmoid colon of HIV-infected and uninfected men","volume":"53","author":"De Rosa","year":"2013","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib187","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/AAC.02278-15","article-title":"HIV-1 alters intestinal expression of drug transporters and metabolic enzymes: implications for antiretroviral drug disposition","volume":"60","author":"Kis","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib188","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1124\/dmd.107.016089","article-title":"Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions","volume":"35","author":"Dixit","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.053_bib189","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1345\/aph.1K615","article-title":"Induction effects of ritonavir: implications for drug interactions","volume":"42","author":"Foisy","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-012-0004-0","article-title":"Nonalcoholic fatty liver disease: current issues and novel treatment approaches","volume":"73","author":"Lomonaco","year":"2013","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib192","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/07853890802552437","article-title":"New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)","volume":"41","author":"Ali","year":"2009","journal-title":"Ann Med"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib193","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease","volume":"39","author":"Lake","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.053_bib194","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib195","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","author":"Lickteig","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.053_bib196","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.xphs.2015.11.008","article-title":"Sandwich-cultured hepatocytes as a tool to study drug disposition and drug-induced liver injury","volume":"105","author":"Yang","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.053_bib197","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/mol.104.004481","article-title":"Role of glycosylation in trafficking of Mrp2 in sandwich-cultured rat hepatocytes","volume":"67","author":"Zhang","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.053_bib198","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/00498254.2016.1144228","article-title":"Proteomic analysis for the impact of hypercholesterolemia on expressions of hepatic drug transporters and metabolizing enzymes","volume":"46","author":"Liu","year":"2016","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib199","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1478-3231.2008.01846.x","article-title":"Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis","volume":"29","author":"Takeyama","year":"2009","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.053_bib200","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.053_bib201","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCRESAHA.111.300194","article-title":"ABCC6 is a basolateral plasma membrane protein","volume":"112","author":"Pomozi","year":"2013","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib202","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/AAC.48.5.1889-1891.2004","article-title":"Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages","volume":"48","author":"Jorajuria","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.053_bib203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/17425255.2.5.651","article-title":"Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy","volume":"2","author":"Ieiri","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.xphs.2017.04.053_bib204","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mam.2016.11.008","article-title":"Epigenetics in non-alcoholic fatty liver disease","volume":"54","author":"Lee","year":"2017","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.053_bib205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/ecp.11.66","article-title":"Inflammation-mediated changes in drug transporter expression\/activity: implications for therapeutic drug response","volume":"5","author":"Cressman","year":"2012","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.053_bib206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.18433\/J30300","article-title":"Effect of inflammation on molecular targets and drug transporters","volume":"15","author":"Hanafy","year":"2012","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.053_bib207","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fphar.2012.00008","article-title":"Immunological response as a source to variability in drug metabolism and transport","volume":"3","author":"Christensen","year":"2012","journal-title":"Front Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T22:26:25Z","timestamp":1658960785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917303222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":207,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022354917303222"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.053","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Liver Disease on Hepatic Transporter Expression and Function","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}